Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) EBT Margin (2020 - 2025)

Historic EBT Margin for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to 19.27%.

  • Cellebrite DI's EBT Margin rose 2106800.0% to 19.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.49%, marking a year-over-year increase of 985200.0%. This contributed to the annual value of 68.79% for FY2024, which is 455500.0% down from last year.
  • Latest data reveals that Cellebrite DI reported EBT Margin of 19.27% as of Q3 2025, which was up 2106800.0% from 18.35% recorded in Q2 2025.
  • Cellebrite DI's 5-year EBT Margin high stood at 79.69% for Q4 2021, and its period low was 191.41% during Q3 2024.
  • For the 5-year period, Cellebrite DI's EBT Margin averaged around 4.81%, with its median value being 12.3% (2022).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -1995500bps in 2024, then surged by 2106800bps in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's EBT Margin stood at 79.69% in 2021, then tumbled by -85bps to 12.3% in 2022, then plummeted by -208bps to 13.27% in 2023, then skyrocketed by 237bps to 18.25% in 2024, then rose by 6bps to 19.27% in 2025.
  • Its last three reported values are 19.27% in Q3 2025, 18.35% for Q2 2025, and 17.97% during Q1 2025.